Facebook LinkedIn Twitter

AbbVie Corporation

AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.

À propos d’AbbVie
AbbVie est une société d’envergure mondiale centrée sur la recherche biopharmaceutique créée en 2013 à la suite de la scission des Laboratoires Abbott. La société a pour mission de mettre à profit son expertise, son personnel dévoué et son approche unique de l’innovation au développement et à la commercialisation de traitements évolués qui répondent à certaines des maladies les plus complexes et les plus graves au monde. AbbVie, y compris sa filiale à part entière, Pharmacyclics, emploie plus de 28 000 personnes et commercialise ses produits dans plus de 170 pays.

Amgen Canada

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.ca and follow us on www.twitter.com/amgen.

ATMA Journey Centers Inc.

We care about improving the lives and practices of healthcare professionals.

ATMA is pioneering a therapist-centred and therapist-driven business model for the psychedelic industry. Education, training, clinical trials, and business support services are all being developed in the largest online community platform for psychedelic practitioners, to assist mental healthcare professionals in adopting psychedelic-assisted therapy into their practices. ATMA provides a clear, guided path for healthcare professionals and clinics to navigate through this process.

BC Children’s Health Research Institute (BCCHRI)

The Research Institute at BC Children’s Hospital conducts discovery, translational and clinical research that benefits the health of children and families.  The institute is supported by BC Children’s Hospital Foundation and works in close partnership with the University of British Columbia, BC Children’s Hospital, and BC Women’s Hospital & Health Centre (agencies of the Provincial Health Services Authority).

BV Medical Research

They are a Site Management Organization (SMO) with an experienced network of clinical research investigators embracing today’s technology to optimize reliability and data quality of clinical trials.

Their team of sites and staff are committed to ensuring optimal patient safety and comfort while upholding ethical conduct and Good Clinical Practice standards.

It is their mission to improve the quality of medicine and treatments available by embracing technology through their decentralized network of highly experienced and involved investigators.

Based out of Niagara Falls, Canada, BC Medical is dedicated to serving their amazing community by accelerating clinical research in the USA and Canada.